Acute onset of ovarian dysfunction in young females after start of cancer treatment

Pediatric Blood and Cancer

Volumn 60, Issue 4, 2013, Pages 676-681

  Mörse, Helena ^a   Elfving, Maria ^a   Lindgren, Anna ^a   Wölner Hanssen, Pål ^a   Andersen, Claus Yding ^b   Øra, Ingrid ^a,c  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Anti M llerian hormone; Childhood cancer; Female; Ovarian reserve; Prepuberty; Puberty

Indexed keywords

ANTINEOPLASTIC AGENT; BUSULFAN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; ESTRADIOL; FLUDARABINE; FOLLITROPIN; IFOSFAMIDE; INHIBIN B; LOMUSTINE; LUTEINIZING HORMONE; MELPHALAN; MUELLERIAN INHIBITING FACTOR; PROCARBAZINE; TEMOZOLOMIDE; THIOTEPA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ANTIMULLERIAN HORMONE BLOOD LEVEL; ARTICLE; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER THERAPY; CARCINOMA; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; ESTRADIOL BLOOD LEVEL; EWING SARCOMA; FANCONI ANEMIA; FEMALE; FOLLITROPIN BLOOD LEVEL; GERM CELL TUMOR; GLIOMA; HODGKIN DISEASE; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; INHIBIN B BLOOD LEVEL; LOW DRUG DOSE; LUTEINIZING HORMONE BLOOD LEVEL; MAINTENANCE CHEMOTHERAPY; MEDULLOBLASTOMA; MENARCHE; NEPHROBLASTOMA; NEUROBLASTOMA; NEUROECTODERM TUMOR; OBSERVATIONAL STUDY; OSTEOSARCOMA; OVARY INSUFFICIENCY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RHABDOID TUMOR; RHABDOMYOSARCOMA; SCHOOL CHILD; SIDE EFFECT; STEM CELL TRANSPLANTATION;

ADOLESCENT; ANTI-MULLERIAN HORMONE; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; INHIBINS; LUTEINIZING HORMONE; NEOPLASMS; PRIMARY OVARIAN INSUFFICIENCY;

EID: 84873710424     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24327     Document Type: Article

References (28)

1. Green DM, Sklar CA, Boice JD, Jr., et al. Ovarian failure and reproductive outcomes after childhood cancer treatment: Results from the Childhood Cancer Survivor Study. J Clin Oncol 2009; 27: 2374-2381.
2. Walshe JM, Denduluri N, Swain SM. Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer. J Clin Oncol 2006; 24: 5769-5779.
3. Sklar CA, Mertens AC, Mitby P, et al. Premature menopause in survivors of childhood cancer: A report from the childhood cancer survivor study. J Natl Cancer Inst 2006; 98: 890-896.
4. Chemaitilly W, Mertens AC, Mitby P, et al. Acute ovarian failure in the childhood cancer survivor study. J Clin Endocrinol Metab 2006; 91: 1723-1728.
5. Vehmanen L, Saarto T, Elomaa I, et al. Long-term impact of chemotherapy-induced ovarian failure on bone mineral density (BMD) in premenopausal breast cancer patients: The effect of adjuvant clodronate treatment. Eur J Cancer 2001; 37: 2373-2378.
6. De Vos M, Devroey P, Fauser BC. Primary ovarian insufficiency. Lancet 2010; 376: 911-921.
7. Andersen CY, Schmidt KT, Kristensen SG, et al. Concentrations of AMH and inhibin-B in relation to follicular diameter in normal human small antral follicles. Hum Reprod 2010; 25: 1282-1287.
8. Broekmans FJ, Visser JA, Laven JS, et al. Anti-Mullerian hormone and ovarian dysfunction. Trends Endocrinol Metab 2008; 19: 340-347.
9. van Rooij IA, Broekmans FJ, Scheffer GJ, et al. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: A longitudinal study. Fertil Steril 2005; 83: 979-987.
10. Kelsey TW, Wright P, Nelson SM, et al. A validated model of serum anti-mullerian hormone from conception to menopause. PLoS ONE 2011; 6: e22024.
11. Bath LE, Wallace WH, Shaw MP, et al. Depletion of ovarian reserve in young women after treatment for cancer in childhood: Detection by anti-Mullerian hormone, inhibin B and ovarian ultrasound. Hum Reprod 2003; 18: 2368-2374.
12. van Beek RD, van den Heuvel-Eibrink MM, Laven JS, et al. Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood. J Clin Endocrinol Metab 2007; 92: 3869-3874.
13. Lie Fong S, Laven JS, Hakvoort-Cammel FG, et al. Assessment of ovarian reserve in adult childhood cancer survivors using anti-Mullerian hormone. Hum Reprod 2009; 24: 982-990.
14. Laporte S, Couto-Silva AC, Trabado S, et al. Inhibin B and anti-Mullerian hormone as markers of gonadal function after hematopoietic cell transplantation during childhood. BMC Pediatr 2011; 11: 20.
15. Cuny A, Trivin C, Brailly-Tabard S, et al. Inhibin B and anti-Mullerian hormone as markers of gonadal function after treatment for medulloblastoma or posterior fossa ependymoma during childhood. J Pediatr 2011; 158: 1016-1022 e1011.
16. Su HI, Sammel MD, Green J, et al. Antimullerian hormone and inhibin B are hormone measures of ovarian function in late reproductive-aged breast cancer survivors. Cancer 2010; 116: 592-599.
17. Lie Fong S, Lugtenburg PJ, Schipper I, et al. Anti-mullerian hormone as a marker of ovarian function in women after chemotherapy and radiotherapy for haematological malignancies. Hum Reprod 2008; 23: 674-678.
18. Partridge AH, Ruddy KJ, Gelber S, et al. Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer. Fertil Steril 2010; 94: 638-644.
19. Anders C, Marcom PK, Peterson B, et al. A pilot study of predictive markers of chemotherapy-related amenorrhea among premenopausal women with early stage breast cancer. Cancer Invest 2008; 26: 286-295.
20. Anderson RA, Cameron DA. Pretreatment serum anti-mullerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer. J Clin Endocrinol Metab 2011; 96: 1336-1343.
21. Decanter C, Morschhauser F, Pigny P, et al. Anti-Mullerian hormone follow-up in young women treated by chemotherapy for lymphoma: Preliminary results. Reprod Biomed Online 2010; 20: 280-285.
22. Rosendahl M, Andersen CY, La Cour Freiesleben N, et al. Dynamics and mechanisms of chemotherapy-induced ovarian follicular depletion in women of fertile age. Fertil Steril 2010; 94: 156-166.
23. Wallace WH, Barr RD. Fertility preservation for girls and young women with cancer: What are the remaining challenges? Hum Reprod Update 2010; 16: 614-616.
24. Schmidt KT, Rosendahl M, Ernst E, et al. Autotransplantation of cryopreserved ovarian tissue in 12 women with chemotherapy-induced premature ovarian failure: The Danish experience. Fertil Steril 2011; 95: 695-701.
25. Donnez J, Silber S, Andersen CY, et al. Children born after autotransplantation of cryopreserved ovarian tissue. A review of 13 live births. Ann Med 2011; 43: 437-450.
26. Brougham MF, Crofton PM, Johnson EJ, et al. Anti-mullerian hormone is a marker of gonadotoxicity in pre- and post-pubertal girls treated for cancer: A prospective study. J Clin Endocrinol Metab 2012; 97: 2059-2067.
27. Holmqvist AS, Wiebe T, Hjorth L, et al. Young age at diagnosis is a risk factor for negative late socio-economic effects after acute lymphoblastic leukemia in childhood. Pediatr Blood Cancer 2010; 55: 698-707.
28. Green DM, Nolan VG, Kawashima T, et al. Decreased fertility among female childhood cancer survivors who received 22-27 Gy hypothalamic/pituitary irradiation: A report from the Childhood Cancer Survivor Study. Fertil Steril 2011; 95: 1922-1927, e1921.